Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 168tk; 150mg 14tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex on näidustatud kasutamiseks adjunctive ravi konfiskeerimiste seotud lennox gastaut sündroom (lgs) või dravet sündroom (ds), koos klobasaam, patsientidel, 2-aastased ja vanemad.

Eesti - eesti - Ravimiamet

chanelle pharmaceuticals manufacturing limited - prasikvanteel+febanteel+püranteel - tablett - 50mg+150mg+50mg 12tk; 50mg+150mg+50mg 100tk; 50mg+150mg+50mg 16tk; 50mg+150mg+50mg 206tk; 50mg+150mg+50mg 80tk; 50mg+150mg+50mg 24tk; 50mg+150mg+50mg 60tk; 50mg+150mg+50mg 280tk; 50mg+150mg+50mg 500tk; 50mg+150mg+50mg 32tk; 50mg+150mg+50mg 120tk; 50mg+150mg+50mg 30tk; 50mg+150mg+50mg 52tk; 50mg+150mg+50mg 1000tk; 50mg+150mg+50mg 18tk; 50mg+150mg+50mg 28tk; 50mg+150mg+50mg 106tk; 50mg+150mg+50mg 6tk; 50mg+150mg+50mg 50tk; 50mg+150mg+50mg 20tk; 50mg+150mg+50mg 36tk; 50mg+150mg+50mg 180tk; 50mg+150mg+50mg 200tk; 50mg+150mg+50mg 150tk; 50mg+150mg+50mg 42tk; 50mg+150mg+50mg 204tk; 50mg+150mg+50mg 90tk; 50mg+150mg+50mg 2tk; 50mg+150mg+50mg 48tk; 50mg+150mg+50mg 10tk; 50mg+150mg+50mg 300tk; 50mg+150mg+50mg 70tk; 50mg+150mg+50mg 8tk

Eesti - eesti - Ravimiamet

chanelle pharmaceuticals manufacturing limited - prasikvanteel+febanteel+püranteel - tablett - 50mg+150mg+50mg 32tk; 50mg+150mg+50mg 200tk; 50mg+150mg+50mg 60tk; 50mg+150mg+50mg 2tk; 50mg+150mg+50mg 150tk; 50mg+150mg+50mg 280tk; 50mg+150mg+50mg 16tk; 50mg+150mg+50mg 52tk; 50mg+150mg+50mg 120tk; 50mg+150mg+50mg 300tk; 50mg+150mg+50mg 70tk; 50mg+150mg+50mg 1000tk; 50mg+150mg+50mg 20tk; 50mg+150mg+50mg 28tk; 50mg+150mg+50mg 80tk; 50mg+150mg+50mg 6tk; 50mg+150mg+50mg 180tk; 50mg+150mg+50mg 12tk; 50mg+150mg+50mg 42tk; 50mg+150mg+50mg 56tk; 50mg+150mg+50mg 48tk; 50mg+150mg+50mg 106tk; 50mg+150mg+50mg 8tk; 50mg+150mg+50mg 30tk; 50mg+150mg+50mg 84tk; 50mg+150mg+50mg 14tk; 50mg+150mg+50mg 100tk; 50mg+150mg+50mg 500tk; 50mg+150mg+50mg 40tk; 50mg+150mg+50mg 204tk; 50mg+150mg+50mg 10tk; 50mg+150mg+50mg 24tk; 50mg+150mg+50mg 250tk; 50mg+150mg+50mg 18tk; 50mg+150mg+50mg 44tk; 50mg+150mg+50mg 98tk; 50mg+150mg+50mg 104tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - febuksostaat - õhukese polümeerikattega tablett - 120mg 84tk; 120mg 42tk; 120mg 98tk; 120mg 28tk; 120mg 14tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - tadalafiil - õhukese polümeerikattega tablett - 10mg 56tk; 10mg 12tk; 10mg 4tk; 10mg 8tk; 10mg 24tk; 10mg 1tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - tadalafiil - õhukese polümeerikattega tablett - 20mg 24tk; 20mg 12tk; 20mg 28tk; 20mg 8tk; 20mg 1tk; 20mg 2tk; 20mg 4tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - febuksostaat - õhukese polümeerikattega tablett - 80mg 42tk; 80mg 98tk; 80mg 84tk; 80mg 28tk; 80mg 14tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - tadalafiil - õhukese polümeerikattega tablett - 2,5mg 28tk; 2,5mg 4tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - prekursorko-lümfoblastne leukeemia-lümfoom - antineoplastilised ained - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.